Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03690609 · ClinicalTrials.gov registry record · NA
CytoQuel: Clinical Documentation on Effects on Chronic Pain, Wellness, and Reduction of Inflammatory Markers
A NA study, sponsored by Natural Immune Systems.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03690609 is a NA study that has completed, run by Natural Immune Systems. The registered enrollment target is 21 participants.
The verdict
NCT03690609, a NA study, has completed, sponsored by Natural Immune Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose for this protocol is to perform an open-label parallel-arm clinical study in healthy subjects to evaluate the efficacy of a nutraceutical product on chronic pain, vascular health, inflammation, and overall wellness.
Interventions
- DIETARY_SUPPLEMENT CytoQuel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-09-21 |
| Est. Completion | 2018-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03690609
The ClinicalTrials.gov registry entry for NCT03690609 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natural Immune Systems, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CytoQuel is the first listed.
NCT03690609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03690609 about?
NCT03690609 is a clinical study titled "CytoQuel: Clinical Documentation on Effects on Chronic Pain, Wellness, and Reduction of Inflammatory Markers". The purpose for this protocol is to perform an open-label parallel-arm clinical study in healthy subjects to evaluate the efficacy of a nutraceutical product on chronic pain, vascular health, inflammation, and overall wellness.
What is the current status of trial NCT03690609?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-09-21. Estimated completion is 2018-01-19.
What interventions are being tested in trial NCT03690609?
The interventions under investigation include: CytoQuel (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03690609?
This trial is sponsored by Natural Immune Systems, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.